ACLX
Price
$83.35
Change
+$1.32 (+1.61%)
Updated
Dec 18, 10:30 AM (EDT)
92 days until earnings call
PTGX
Price
$40.77
Change
-$0.70 (-1.69%)
Updated
Dec 17, 04:59 PM (EDT)
90 days until earnings call
Ad is loading...

ACLX vs PTGX

Header iconACLX vs PTGX Comparison
Open Charts ACLX vs PTGXBanner chart's image
Arcellx
Price$83.35
Change+$1.32 (+1.61%)
Volume$1.41K
CapitalizationN/A
Protagonist Therapeutics
Price$40.77
Change-$0.70 (-1.69%)
Volume$8.33K
CapitalizationN/A
ACLX vs PTGX Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. PTGX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and PTGX is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ACLX: $82.03 vs. PTGX: $40.69)
Brand notoriety: ACLX and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 115% vs. PTGX: 77%
Market capitalization -- ACLX: $4.44B vs. PTGX: $2.43B
ACLX [@Biotechnology] is valued at $4.44B. PTGX’s [@Biotechnology] market capitalization is $2.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 1 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 1 bullish, 7 bearish.
  • PTGX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -0.30% price change this week, while PTGX (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.84%. For the same industry, the average monthly price growth was +1.08%, and the average quarterly price growth was +4.66%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

PTGX is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-4.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.44B) has a higher market cap than PTGX($2.43B). PTGX YTD gains are higher at: 77.453 vs. ACLX (47.793).
ACLXPTGXACLX / PTGX
Capitalization4.44B2.43B183%
EBITDAN/AN/A-
Gain YTD47.79377.45362%
P/E RatioN/A14.85-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXPTGX
RSI
ODDS (%)
Bearish Trend 6 days ago
70%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 7 days ago
75%
BollingerBands
ODDS (%)
N/A
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-1.67%
BEAM - ACLX
49%
Loosely correlated
-1.21%
DNLI - ACLX
48%
Loosely correlated
-0.30%
RCUS - ACLX
47%
Loosely correlated
-2.60%
RCKT - ACLX
47%
Loosely correlated
+1.36%
CRSP - ACLX
47%
Loosely correlated
+0.88%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with ACLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
-1.86%
ACLX - PTGX
41%
Loosely correlated
-1.67%
RCKT - PTGX
40%
Loosely correlated
+1.36%
ARDX - PTGX
40%
Loosely correlated
-13.54%
BEAM - PTGX
40%
Loosely correlated
-1.21%
VRDN - PTGX
40%
Loosely correlated
-3.34%
More